Addyi, medical name flibanserin, is designed for women diagnosed ... One of the main reasons Addyi hasn’t been approved in the UK is that European regulators (the European Medicines Agency ...
In the United States, two drugs have been approved to treat female sexual interest/arousal disorder (FSIAD): Vyleesi (bremelanotide) and Addyi (flibanserin). Some people may refer to these as “V ...
Whether the “little pink pill” is a boon or a boondoggle depends on who you ask Flibanserin, soon to be marketed as Addyi, has been in clinical trials to treat low desire since the mid-2000s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results